Naturally Splendid (TSXV:NSP) announces its financial results for the three months ended March 31, 2018. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards.

Naturally Splendid recorded a net loss of $13,397 during the three months ended March 31, 2018, compared to a loss of $942,055 during the three months ended March 31, 2017. The decrease in net loss was due to the sale of POS BPC Manufacturing Corp. which provided for a gain on sale of $1,535,096, offset by an increase in selling and distribution costs of $88,479 and administrative expenses of $453,230, mainly due to the addition of the Company’s Prosnack Natural Foods Inc. (“Prosnack”) business which was not included in the expenses in the comparative quarter, as the acquisition occurred on October 18, 2017.


Naturally Splendid recorded sales of $320,827 during the three months ended March 31, 2018 compared to $587,203 in for the three months ended March 31, 2017. This revenue decrease was mainly due to the collapse of sales of bulk hemp seed to South Korea where the Company had recorded $Nil bulk sales in the current quarter compared to $245,400 in the first quarter of 2017. The additional sales generated from the acquisition of the Prosnack business was not enough to counter the loss of bulk sales. Retail sales were off during the first quarter whereas online sales remained consistent.

Cost of Sales during the three months ended March 31, 2018 was $217,523, compared to $435,766 in the three months ended March 31, 2017. The Company significantly changed its sales mix in 2018 with a reduction of exporting bulk seed sales which have been generally sold at a lower gross margin percentage.

Gross profits during the three months ended March 31, 2018 was $103,304 (32.2% of sales) compared to $151,437 (25.8%) in the three months ended March 31, 2017 due to higher margins on retail and online sales whereas in the comparative quarter the lower margins on bulk seed sales caused the overall margins to decrease. In 2018, the Company is focused on rebuilding its markets and products and new commercial opportunities, both domestically and in new international markets, and with NSE’s acquisitions of Prosnack (acquired October 18, 2017) and Absorbent Concepts Inc. (“ACI”) (acquired April 24, 2018).

Statements of Loss Data For the Three Months Ended March 31, 2018
$
For the Three Months Ended March 31, 2017
$
Total Revenue 320,827 587,203
Cost of sales (217,523) (435,766)
Selling and distribution expenses (228,722) (140,243)
Administrative Expenses (1,418,647) (965,417)
Other Income 1,530,668 12,168
Net Loss (13,397) (942,055)
Basic and Diluted Loss Per Share (0.00) (0.01)

Internationally, current market trends and pricing have demonstrated severe margin reductions and an over supply of hemp seeds in South Korea. We will continue to maintain relationships with our distributors as this mature market has consumer demand in other hemp-based products. In the German market, the Company will continue efforts to increase sales of its NATERA(R) product line via the Naturally Splendid ecommerce platform. Advertising and promotional activities are being developed to build more awareness and generate sales opportunities in this market. Naturally Splendid has invested a year of research and due diligence to gain access to the Japanese CBD market. This vital and necessary process cannot be circumvented in order to have orderly and lawful approval of our products. By persevering, the Company hopes to secure a sales base and access to this lucrative market. In Australia, the Company has developed a relationship with a major distributor that has access to five key market segments; Veterinarians, Retail, Food Service, Health Practitioners and Ecommerce. The Company is preparing to market its NATERA(R) and Elevate Me(TM) brands of products (hemp seeds & hemp protein conventional and organic and bars) to satisfy three of the five sectors as an initial launch; allowing for market research, customer acceptance and development of logistical elements to prepare for further key market segment penetration and product introductions.

Company CEO Doug Mason states, “In the first quarter of my term as CEO, I evaluated the projects and opportunities in front of the Company. During this period, we set strategic initiatives to drive significant growth for Naturally Splendid, including divesting of the Company’s interest in POS BPC Manufacturing Corp. for a profit of $1.5M. We identified and negotiated to purchase a company, Absorbent Concepts Inc., that would enable the Company to become a truly vertically integrated, industrial hemp and biotech and consumer products company. Recognizing the significant market opportunities, we also began the process of becoming a Licensed Dealer in Canada, that upon successfully completing will allow the company to extract and manufacture multiple CBD fortified products. We have empowered the product development team at Naturally Splendid to leverage our unique and proprietary technologies, and to create additional business opportunities utilizing our recently acquired and expanded operations. Additionally, we put a new CFO in place adding strong financial expertise to our management team.”

Naturally Splendid’s financial statements can be viewed on SEDAR.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, and we are producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.

Naturally Splendid currently has four innovative divisions:

  1. (1)BIOTECHNOLOGY – Focused on three major platforms:
  1. (1)Proprietary HempOmega(TM) encapsulation
  1. (2)Extraction and formulation with Cannabidiol (CBD)
  1. (3)Hemp and plant-based proteins.

(2) CONSUMER PRODUCTS –

-NATERA(R) – brand of retail hemp and superfood products distributed throughout North America, Asia and Europe.

-Prosnack Natural Foods Inc. (Elevate Me(TM)) – lifestyle brand of healthy meal replacement products distributed throughout North America.

-Chi Hemp Industries Incorporated (CHII) – e-commerce platform for natural and organic hemp products.

-PawsitiveFX(R) – topical pet care products.

-NATERA(R)CBD – retail hemp-based cannabinoid nutraceutical and cosmeceutical products distributed in Asia.

-NATERA(R)Skincare – brand of retail hemp based cosmeceutical products.

(3) NATERA(R) Ingredients – bulk ingredients including HempOmega(TM).

(4) Co-Packaging/Toll-Processing – packaging for house-brands (NATERA(R) and CHII) and third-party partners.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. Douglas Mason

CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 465-0548

Fax: (604) 465-1128

E-mail: info@naturallysplendid.com

Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation. 

Source: www.thenewswire.com

PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to provide a corporate update on its psychedelic pharmaceuticals program. Since its inception, the Company has built a unique product pipeline for novel uses of ketamine, psilocybin and undisclosed psychedelics. PharmaTher is positioning itself to partner its psilocybin program and panaceAI™, and focus on advancing its novel ketamine product pipeline in Parkinson’s disease, depression and pain via the U.S. Food and Drug Administration (“FDA”) regulatory pathway.

“We have made tremendous progress over the last several months that saw our product pipeline evolve to focus on the massive opportunity and potential of ketamine, an FDA approved drug with a known safety profile, to treat significant unmet medical needs for Parkinson’s disease, depression and pain,” said Fabio Chianelli, CEO of PharmaTher. “With our focus on ketamine through repurposing, combining it with an FDA approved drug and delivering it with our novel microneedle delivery system, we are now positioned to expedite our clinical development objectives by taking advantage of the FDA’s 505(b)(2) regulatory pathway and commercializing disruptive ketamine treatments for mental health and pain disorders.”

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB)(TSX: ACB), and Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED).

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

Chemesis International Inc. (the “Company”) (CSE:CSI)(OTCQB:CADMF)(FRA:CWAA

The Company announces that its (former) subsidiary, Natural Ventures PR, LLC (“NVPR”), has sold all of its cannabis assets, and assigned all related liabilities, licenses and permits, to Puerto Rico Industrial Commercial Holdings Biotech Corp. (“PRICH”) in exchange for immediate net cash proceeds to the Company, in respect of its 80% interest in NVRP, of US$450,000. The Company notes that, in connection with, and as a condition to, this transaction, it will cease to be a shareholder of NVPR.

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), an emerging leader in reducing the carbon footprint of cement products using natural pozzolans, is pleased to announce it has sold and optioned a combined total of 10 million of its 10.5 million shares of Snow Lake Resources.

The sale and option agreements were made with two arms-length purchasers. The first sale was for 1,700,000 shares at $0.04 per share for a total of $68,000 and includes an option granted by PLAN entitling the same party to purchase an additional 4,966,666 shares at $0.04 per share until May 11, 2021 . The second sale was for 1,250,000 shares at $0.04 per share for a total of $50,000 and includes an option granted by PLAN to such party to purchase an additional 2,083,334 shares until August 14, 2021 . As at the date of this news release, PLAN has received $116,000 and will receive another $284,000 if the remaining shares are purchased under the option agreements.

Keep reading... Show less

First Products to Hit California Shelves in Q2 2021

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that its fully funded state of the art 185,000 square foot production facility in Commerce, California is nearing completion and will be ready to serve the $3b California cannabis market in Q2 2021. The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May.

Keep reading... Show less